Cart
sales@molnova.com
CID-1067700
CAS No. 314042-01-8
CID-1067700( —— )
Catalog No. M20841 CAS No. 314042-01-8
CID-1067700 is one of the first identified competitive inhibitors of nucleotide binding by Ras-related GTPases（Rab7 with a Ki of 13 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 40 | Get Quote |
|
| 5MG | 61 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 178 | Get Quote |
|
| 50MG | 233 | Get Quote |
|
| 100MG | 302 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCID-1067700
-
NoteResearch use only, not for human use.
-
Brief DescriptionCID-1067700 is one of the first identified competitive inhibitors of nucleotide binding by Ras-related GTPases（Rab7 with a Ki of 13 nM).
-
DescriptionCID-1067700 is one of the first identified competitive inhibitors of nucleotide binding by Ras-related GTPases（Rab7 with a Ki of 13 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRab7
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number314042-01-8
-
Formula Weight390.48
-
Molecular FormulaC18H18N2O4S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:68 mg/mL(174mM)Need?ultrasonic
-
SMILESCC1(C)Cc2c(sc(NC(=S)NC(=O)c3ccccc3)c2C(=O)O)CO1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Agola J O Hong L Surviladze Z et al. A Competitive Nucleotide Binding Inhibitor:\r?In Vitro\r Characterization of Rab7 GTPase Inhibition[J]. ACS Chemical Biology 2012 7(6):1095-1108.
molnova catalog
related products
-
ZT-12-037-01
ZT-12-037-01 is a potent, selective, ATP-competitive STK19 inhibitor with IC50 of 20.04 nM measured as percentage of NRAS phosphorylation.
-
ML-210
A small-molecule probe that selectively kills cells induced to express mutant RAS; inhibits BJeLR (expressing HRAS G12V) cell lines with IC50 of 25 nM.
-
ADT-007
ADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.
